Virtus ETF Advisers LLC Biomarin Pharmaceutical Inc Transaction History
Virtus ETF Advisers LLC
- $70.5 Million
- Q1 2025
A detailed history of Virtus ETF Advisers LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 2,870 shares of BMRN stock, worth $155,209. This represents 0.29% of its overall portfolio holdings.
Number of Shares
2,870
Previous 5,277
45.61%
Holding current value
$155,209
Previous $346,000
41.62%
% of portfolio
0.29%
Previous 0.15%
Shares
29 transactions
Others Institutions Holding BMRN
# of Institutions
668Shares Held
184MCall Options Held
1.24MPut Options Held
957K-
Black Rock Inc. New York, NY22.7MShares$1.23 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.03 Billion0.03% of portfolio
-
Primecap Management CO Pasadena, CA17.8MShares$961 Million1.06% of portfolio
-
Dodge & Cox San Francisco, CA15MShares$809 Million0.65% of portfolio
-
Viking Global Investors LP10.8MShares$584 Million2.55% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $10B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...